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The lower urinary tract’s virtually inevitable exposure
to external microbial pathogens warrants efficient
tissue-specialized defenses to maintain sterility.
The observation that the bladder can become chron-
ically infected in combination with clinical observa-
tions that antibody responses after bladder infec-
tions are not detectable suggest defects in the
formation of adaptive immunity and immunological
memory. We have identified a broadly immunosup-
pressive transcriptional program specific to the
bladder, but not the kidney, during infection of the
urinary tract that is dependent on tissue-resident
mast cells (MCs). This involves localized production
of interleukin-10 and results in suppressed humoral
and cell-mediated responses and bacterial persis-
tence. Therefore, in addition to the previously
described role of MCs orchestrating the early innate
immunity during bladder infection, they subse-
quently play a tissue-specific immunosuppressive
role. These findings may explain the prevalent recur-
rence of bladder infections and suggest the bladder
as a site exhibiting an intrinsic degree of MC-
maintained immune privilege.
INTRODUCTION
Peripheral tolerance is rigorously maintained in certain tissue
microenvironments, limiting the function and scope of immune
responses and promoting relative immune privilege (Mellor and
Munn, 2008). Immune-privileged sites (such as tumors) and
organs (such as the gut and liver) have specialized strategies
that increase the threshold for immune activation. Mechanisms
that dampen immune responses are highly varied and can
include the production of the predominately immunosuppressive
cytokine IL-10, activation of antigen-specific T regulatory (Treg)
cells, and constraint of dendritic cell (DC) activation or function
(Belkaid and Chen, 2010; Francisco et al., 2010; Steinbrink
et al., 1997; Waldmann, 2006). Many questions remain regarding
how a tolerogenic microenvironment affects immunity topathogens but some evidence suggests that relative immune
tolerance can be exploited by pathogens to maintain or initiate
infection. For example, malarial parasites (genus Plasmodium)
can remain latent in the liver, also a site of relative immune toler-
ance (Knolle and Gerken, 2000), and subsequently restore fulmi-
nant infection (Prudeˆncio et al., 2006). Certain anatomical loca-
tions are more susceptible to recurrent infections, including the
bladder.
The bladder is a specialized mucosal tissue where the
immune regulatory networks remain mostly unexplored. This
organ has not traditionally been considered a functionally
immune privileged site, particularly in light of a wealth of litera-
ture describing productive innate immune responses by the
bladder to uropathogens (Haraoka et al., 1999; Mulvey et al.,
2000; Song et al., 2007). Nevertheless, the bladder also experi-
ences a high level of recurrent infections, raising the question of
where the balance lies for this organ with respect to the deci-
sion to maintain or break tolerance. With its unique physiology
and function of storing host waste products, it is crucial for
the bladder to balance host defense and the need to limit
inappropriate responses to self-products and minimize tissue
damage.
Mostly caused by uropathogenic E. coli (UPEC), urinary tract
infections (UTIs) are the second most common bacterial infec-
tion in humans (Hagberg et al., 1981; Hooton et al., 1996) and
many are recurrent (Foxman, 1990). Although the underlying
basis is not known, the high frequency of recurring UTIs
suggests a defect in immunological memory formation subse-
quent to bladder infection. UTIs can involve only the bladder,
but a significant number also progress to the kidneys. Interest-
ingly, clinical observations indicate that bladder infections,
unlike kidney infections, fail to evoke detectable pathogen-
specific antibodies in the serum and urine (Percival et al., 1964;
Ratner et al., 1981; Rene and Silverblatt, 1982; Sanford et al.,
1978; Winberg et al., 1963). These observations seem counterin-
tuitive because bladder infections are typically accompanied by
a robust innate immune response involving vigorous IL-6 and
IL-8 production and large numbers of neutrophils in the urine
(Fihn, 2003; Nielubowicz and Mobley, 2010; Stamm, 1983).
Hence, there appears to be a disconnect between innate and
adaptive immune responses in the bladder during infection. In
this work, we sought to elucidate the underlying basis for the
muted adaptive responses in the bladder and to explain the
unique persistence of infection associated with this organ.Immunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc. 349
Figure 1. Bladders Fail to Eradicate Persistent E. coli
(A) Mice were infected either in the bladder or with concurrent bladder and
kidney infections and the organs were homogenized and plated on bacterial
agar for growth to quantitate the CFUs of bacteria per organ. Although the
kidneys are able to completely clear infection within 3 days, the UPEC in the
bladder persist for more than 4 weeks. All data are representative of three
independent experiments, nR 3 per time point; error bars represent ±SEM.
(B) E. coli (red) remain within the intermediate (green) and superficial bladder
epithelium (blue) 2 weeks p.i. (basement membrane denoted by white line).
Scale bar represents 50 mm.
See also Figure S1.
Figure 2. A Mouse Model Distinguishing between Cystitis and
Pyelonephritis
(A) Similar bacterial CFUs are obtained from bladders during both methods of
infection; bacteria are cultured only from kidneys of pyelonephritis-infected
mice. All data are representative of two independent experiments, n = 3–4 per
time point; error bars represent ±SEM.
(B) Only mice with acute pyelonephritis show significant serum anti-UPEC IgG
geometric mean titers (GMT) after infection. Dotted line denotes threshold of
detection. *p < 0.05; **p < 0.01. Error bars represent the 95% confidence level;
n = 4–6.
See also Figure S2.
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UPEC Persist in the Bladder but Not the Kidneys
UTIs are typically accompanied by a robust innate inflammatory
response involving neutrophil recruitment, which is capable of
resolving the acute phase of bacterial infection (Haraoka et al.,
1999; Mulvey et al., 2000; Nielubowicz and Mobley, 2010).
However, others and we have observed a remarkable persis-
tence of E. coli within the bladder, a hallmark of UTI infection
(Malaviya et al., 1999; Mulvey et al., 2001; Mysorekar and
Hultgren, 2006). When UTIs were initiated with UPEC, high
colony forming units (CFU) could be recovered from bladders
and kidneys 12 hr after infection. Complete clearance was
achieved in the kidneys within 5 days (Figure 1A). Nevertheless,
in the bladder, a population of bacteria persisted (Figure 1A) and
could be viewed within or underneath the superficial bladder
epithelium weeks later (Figure 1B). It should be noted that acute
infectionwithin the bladder subsides by 3 days, evidenced by the
urine being sterile (Figure S1A available online) and the return of
neutrophil detection to homeostatic levels (Figure S1B). Not only
could persistent UPEC potentially act as a reservoir of bacteria
for recurrent infections, but these findings also suggest that
there is a bladder-specific shortfall in host immunity that is not
applicable to the entirety of the urinary tract.
A Mouse Model of Bladder-Restricted Infection
To investigate the isolated influence of the bladdermicroenviron-
ment on immunity, we developed a model where infection was
restricted to this tissue. Although much mechanistic knowledge
of UTIs has come from mouse models, these have rarely distin-
guished infection of the bladder alone (cystitis) from pyelone-
phritis, where pathogens also colonize the kidney via the ureter.
Evidence from human patients suggests that these two UTIs
are highly divergent with regards to the profile of adaptive
immune responses elicited (Percival et al., 1964; Ratner et al.,350 Immunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc.1981; Rene and Silverblatt, 1982; Sanford et al., 1978; Winberg
et al., 1963), so we developed two models of experimental
UTIs where infection either was contained exclusively in the
bladder or extended to the kidneys (replicating the clinical
phenomena of cystitis and pyelonephritis, respectively). To
induce pyelonephritis, we instilled UPEC in a larger volume
with pressure so that a spontaneous retrograde flow (vesicoure-
teral reflux, VUR) from bladder to the kidneys would occur. Using
Evans blue dye (EBD) to track our inoculum, we examined the
lymph nodes (LNs) draining the bladder or kidney. In our pyelo-
nephritis model, dye entered the iliac LNs (ILNs), which are the
draining LNs (DLNs) for the bladder, as well as those that drain
the kidneys, the renal LNs (RLNs) (Figure S2). However, in our
cystitis-only model, dye was present only in the ILNs and not
the RLNs (Figure S2), suggesting that the inoculum did not reflux
into the kidneys. To support these visual observations, we deter-
mined the bacterial burden in the bladder and kidney for each
model. CFUs were comparable in the bladders for both infec-
tious models 12 hr after infection, and bacteria were not present
in the kidneys in our model of bladder-restricted infection (Fig-
ure 2A). These data confirm that we have a working model to
examine bladder-specific immune responses in an infectious
context.
Numerous reports examining human patients have showed
that those with cystitis alone fail to evoke significant pathogen-
specific antibody titers (Percival et al., 1964; Rene and Silver-
blatt, 1982; Sanford et al., 1978; Winberg et al., 1963). This
suggests that individuals with bladder-restricted infections fail
to develop an observable adaptive immune response. To inves-
tigate this phenomenon in our two murine UTI models, we
induced either cystitis or cystitis with pyelonephritis and tested
for the presence of E. coli-specific antibodies in the sera from
each group. In line with the clinical reports, mice with bladder-
restricted infections fail to induce significant E. coli-specific anti-
bodies over naive mice (p > 0.05); however, concurrent kidney
Figure 3. Bladder-Contained Infections Fail to Evoke Significant
Antibody Responses Unless Primary Immunity Was Already Estab-
lished
(A) Mice were infected transurethrally with 13 108 CFU to induce cystitis-only
or pyelonephritis (first arrow) and serum GMT UPEC antibodies were
measured (x axis shows days p.i.). On day 21 (second arrow) cystitis-only was
induced in both groups. *p < 0.05; **p < 0.01; ***p < 0.001, compared to naive.
Error bars represent the 95% confidence level with n = 4–7. Dotted line
denotes threshold of detection.
(B) Naive mice that were adoptively transferred splenocytes from mice that
previously had acute pyelonephritis show enhanced bacterial clearance
5 days postcystitis challenge, compared to control naive mice or mice adop-
tively transferred splenocytes from mice that previously had cystitis only. *p <
0.05. Error bars represent ±SEM with n = 4–6.
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response (Figure 2B). Anti-E. coli IgA responses were also
detectable only in mice with kidney infections (data not shown),
supporting the theory that mucosal responses are similarly diver-
gent to serological responses. With this, we have developed
infectiousmousemodels that distinguish between bladder infec-
tion alone and bladder infection involving the kidneys, and we
identified site-specific defects in adaptive immunity similar to
the human clinical picture.
Impaired Immunological Memory to Bladder Infection
Because persistent infection in the bladder is observed (Figures
1A and 1B) and recurrent infection is typical of human cystitis
(Foxman, 2002), we sought to further define the host’s adaptive
immune response and immunological memory formation after
bladder infection, suspecting that bladder infections are unable
to induce appropriate immunological memory. For these studies,
either a bladder-restricted infection (cystitis) or combined
bladder and kidney infection (pyelonephritis) were induced in
mice on day 0 (Figure 3A, first arrow). Serum antibodies against
E. coliweremeasured every 7 days postinfection (p.i.). Again, we
observed a high anti-E. coli titers inmicewith prior pyelonephritis
and a lack of substantial E. coli antibody titers inmice having had
cystitis. On day 21 (Figure 3A, second arrow) both groups ofmice
(cystitis alone versus pyelonephritis) were reinfected by the
cystitis-only model with the same E. coli strain as the primary
challenge. As expected, upon a second infection, mice with prior
pyelonephritis showed a strong secondary antibody response to
UPEC (Figure 3A). Although higher titers compared to the
primary response (one hallmark of memory responses) were
not observed at the time points assayed, this memory response
was characterized by a prolonged duration of detectable anti-
body responses compared to the first infection (Figure 3A).
However, mice that had a primary infection restricted to thebladder showed no significant (p > 0.05) memory recall response
to cystitis rechallenge (Figure 3A), pointing to a tempering of the
adaptive immunity in the bladder that does not follow the normal
pattern for a secondary humoral response. These observations
suggest that if adaptive immune responses have already been
established, the bladder is immunologically competent to
respond, but that a primary infection of the bladder alone has
limited ability to initiate productive immunological memory.
To investigate the functionality of memory lymphocytes and
confirm this absence of protective immunological memory
subsequent to bladder infection, we performed adoptive transfer
experiments. Mice were infected to initiate bladder-restricted, or
bladder combinedwith kidney, infections. Splenocytes were iso-
lated 21 days p.i. and transferred i.v. into naive hosts. Three days
after transfer, mice were challenged with a bladder infection,
after which the E. coli CFUs still present in the bladder 5 days
p.i. were analyzed. Naive mice with splenocytes transferred
from pyelonephritis-infected mice showed significantly in-
creased bacterial clearance as compared to both naive mice
and mice given splenocytes from mice with bladder-restricted
cystitis (p < 0.05) (Figure 3B). Therefore, whereas the host is
able to gain protective immunological memory in the context of
a UTI involving the kidney, a primary infection of the bladder
alone fails to generate a sufficient memory response to enhance
bacterial clearance during reinfection.
The Bladder, Unlike the Kidney, Maintains a Tolerogenic
Environment during Infection
To better understand the underlying differences in immunity
between the bladder and kidney, we studied the cytokine profile
of both organs during E. coli infection in the time frame when
adaptive immune responses should be induced and refined. As
expected, a strong proinflammatory response, demonstrated
by the drastic upregulation of cytokine expression, including
Il6, Cxcl1 (a functional homolog of Il8), and Tnf (Figures 4A–
4C), was observed early in infection. However, 6 hr p.i., during
both cystitis and pyelonephritis, there was upregulation in the
bladder of a major inhibitor of proinflammatory immune
responses, Il10, which was distinctly absent in the kidney (Fig-
ure 4D). Additional negative regulators of inflammation were
also upregulated: suppressor of cytokine signaling 3 (Socs3),
a negative regulator of cytokine signaling that inhibits activation
and/or differentiation pathways in macrophages, DCs, and
T cells (Hagberg et al., 1983), as well as Tgfb, a broadly acting
anti-inflammatory regulator (Figures 4E and 4F). However, both
Tgfb and Socs3 expression were not detected in the kidneys
after infection. Unlike the proinflammatory responses in the
bladder that begin within 2 hr, peak at 6 hr, and begin resolving
by 24 hr (Figures 4A–4C), this secondary wave of enhanced
expression of anti-inflammatory cytokines and signaling
intermediaries persists throughout the first 3 days of infection
(Figures 4D–4F), a critical time for the development of adaptive
responses. These observations demonstrate that subsequent
to strong proinflammatory innate responses, the bladder specif-
ically responds to UPEC infection with a second, tolerogenic
phase of response involving the induction of anti-inflammatory
master regulators.
In view of the relatively high degree of Il10 upregulation in the
bladder, we focused on IL-10 as a target immunosuppressiveImmunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc. 351
Figure 4. Enhanced Il10 Transcription Typifies the Anti-inflammatory Program upon Infection and Limits Bacterial Clearance and Serum
Antibodies
(A–D) Cytokine transcriptional profile in the bladder and kidney at various times p.i. determined by real-time PCR for Il6 (A), Cxcl1 (B), Tnf (C), and Il10 (D).
(E and F) In addition to Il10 upregulation, significantly increased levels of other major anti-inflammatory mediators—Socs3 (E) and Tgfb1 (F)—were also seen only
in the bladder and were not detected in the kidney. *p < 0.05, **p% 0.01; error bars represent ±SEM. All data are representative of two or more independent
experiments, nR 3.
(G and H) Il10/mice have better bacterial clearance in the bladder as compared to WT mice (G) 5 days and (H) 6 weeks after infection. *p < 0.05, ***p < 0.001;
n = 10–12 mice per group (5 days) and n = 5–6 mice per group (6 weeks).
(I) Significant serum GMT anti-UPEC IgM antibodies are seen in both cystitis-only and mice with pyelonephritis in Il10/mice at comparable titers to mice with
concurrent cystitis and pylenophritis infection at 7 days p.i. There are no significant differences in antibody titers betweenWTmice with pyelonephritis and Il10/
infected mice. UPEC-specfic IgM was not detected in WT mice with cystitis alone. ND indicates not detected, ***p < 0.001. Error bars represent the 95%
confidence level with n = 5–7.
See also Figure S3.
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bladder infection. To discern the functional consequence of
IL-10 during bladder infection, we infected Il10-deficient mice352 Immunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc.(Il10/) with E. coli, using our model of cystitis, and determined
that the load of persistent bacteria was still present in the bladder
5 days p.i. We saw that Il10/ mice had significantly fewer
Figure 5. Suppression of DC Activation in
ILN during Cystitis
(A) Numbers of DCs draining to the ILN and RLN
upon cystitis or pyelonephritis were determined by
flow cytometry by staining for MHC-II and CD11c,
24 hr after infection with 1 3 108 UPEC. Data do
not differ significantly.
(B) Increased numbers of activated DCs (MHCII+
CD11c+CD86+) were present in the RLNs of WT
mice and in ILN of Il10/ mice, similarly infected.
(C and D) WT mice have fewer (C) Th cells (CD4+)
and (D) germinal center B cells (CD19+GL7+) in
LNs 7 days p.i.
*p < 0.05, **p < 0.01; error bars represent ±SEM.
All data are representative of two or more experi-
ments with n = 3–7. Representative flow cytometry
plots are shown in Figure S4.
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after acute infection (5 days) (p < 0.001) (Figure 4G) as well as
a lower number of persisting bacteria in the bladder at 6 weeks
(Figure 4H), indicating that bacterial clearance is enhanced in
the absence of IL-10. Both cystitis- and pyelonephritis-infected
mice had IgG titers against E. coli that were noticeably above
that of naive Il10/ mouse sera, although the titers of Il10/
mice were still lower than those of WT mice (Figure S3). Studies
have shown that IL-10 is important for mediating immunoglob-
ulin class switching in B cells (Malisan et al., 1996; Vanderford
et al., 2010), and this may explain why the detected IgG sera
titers against E. coli were lower in Il10/ mice than in WT mice
(Figure S3). IgM is the first antibody subclass that is produced
in a naive host and, therefore, not likely to be greatly impacted
by the class-switch defect in Il10/mice. In view of this, we as-
sayed for E. coli-specific IgM antibodies in both WT and Il10/
mice infected with cystitis alone or cystitis concurrent with
pyelonephritis to provide a more accurate picture of the magni-
tude of antibody responses without the role of IL-10 in class-
switching complicating the picture. We saw higher titers of IgM
antibodies in sera collected from Il10/ mice with a bladder-
restricted infection, in contrast with WT mice (Figure 4I). These
results indicate that without IL-10, the bladder is able to initiate
a functional adaptive immune response to cystitis.
To investigate the mechanism underlying IL-10-mediated
suppression of responses in the bladder, we examined the initial
events in the induction of adaptive immunity. We suspected that
DC migration might be differentially affected during cystitis with
and without pyelonephritis but observed no difference in the
numbers of DCs within the ILN or RLN upon bladder or kidney
infection, respectively, in the initial hours of infection (Figure 5A).
Migration of DCs is only one aspect required for efficient activa-
tion of adaptive immunity within DLNs; antigen-presenting cellImmunity 38, 349–359,(APC) activation, including costimulatory
molecule expression, is also important
for activation of naive T cells. Along these
lines, we observed significantly greater
numbers of activated DCs, expressing
the costimulatory molecule CD86, in the
RLN of WT mice during kidney infection,
but not in the ILNs draining the bladder(p < 0.05) (Figure 5B). Because we observed that Il10/ mice
respond to bladder infection with adaptive responses of greater
magnitude than did WT mice and because the upregulation of
costimulatory molecules on DCs has been established to be
influenced by IL-10 (Enk et al., 1993; Steinbrink et al., 1999,
1997), we next investigated the influence of IL-10 on the process
of DC activation during cystitis. Il10/mice showed significantly
greater numbers of CD86+ DCs in the ILN as compared to ILN
from WT mice during cystitis (p < 0.01) (Figure 5B). Probably
as a consequence of having fewer activated DCs draining to
the ILN,WTmice with cystitis had significantly reduced numbers
of CD4+ T helper (Th) cells (Figure 5C) and reduced numbers of
germinal center B cells (CD19+GL7+) 7 days p.i. (Figure 5D).
Therefore, increase of IL-10 in the bladder upon infection influ-
ences the activation of LN-draining DCs and may explain the
uniquely dampened adaptive immune responses to bladder
infection.
MCsMediate IL-10-Dependent Suppression of Adaptive
Immunity in the Bladder
With the observation that IL-10 expression increased in the
bladder 6 hr p.i., we sought to find the source of this anti-inflam-
matory cytokine. One immune cell that has been shown to
produce IL-10 during inflammation is the MC (Grimbaldeston
et al., 2007). Although better known for their roles in exacerbating
asthma (Kobayashi et al., 2000; Williams and Galli, 2000) and in
providing immunosurveillance for pathogens (Abraham and St.
John, 2010; Chan et al., 2012; Kalesnikoff and Galli, 2008),
MCs also appear to have roles in maintaining tissue homeo-
stasis. For example, they have been shown to be promote the
maintenance of Treg cell tolerance to allographs (Lu et al.,
2006) and it has been reported that MCs limit inflammation in
an IL-10-dependent manner during contact hypersensitivityFebruary 21, 2013 ª2013 Elsevier Inc. 353
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the context of cutaneous sterile inflammation have recently
been contested (Dudeck et al., 2011), they raise the question
of whether MCs could also temper inflammation in an infectious
context within the bladder. MCs are also well positioned, physi-
cally, to serve this role in the bladder, being located in high
abundance beneath the uroepithelium at the host-environment
interface (Figure 6A). However, we have previously reported
that MCs can respond to infection of the bladder and play
a crucial proinflammatory role in recruitment of neutrophils for
bacterial clearance (Malaviya et al., 2004), as well as recruitment
of APCs to the site of infection (Shelburne et al., 2009). Therefore,
we next investigated whether, in contrast to their function initi-
ating proinflammatory responses (Abraham and St. John,
2010; Chan et al., 2012; Malaviya et al., 2004; Shelburne et al.,
2009), MCs play a secondary function in the bladder by
promoting IL-10-mediated suppression of adaptive immunity.
We observed that basal Il10 expression in the bladder was lower
in MC-deficient (Wsh) mice compared to WT mice (Figure 6B).
Therefore, even under homeostatic conditions, MCs appear to
contribute to IL-10 production in the bladder. At 6 hr p.i., WT
mice had increased IL-10 expression in the bladder, which was
not seen inWshmice (Figure 6C). The kidneys also have resident
MCs but, in contrast to the observation that bladder MCs
contribute to basal IL-10 levels (Figure 6B), the basal level of
IL-10 was higher in kidneys of Wsh mice (Figure 6D). In Wsh
mice, IL-10 levels also dropped dramatically during infection
(Figure 6E). To determine whether bladder MCs, themselves,
were a significant source of IL-10, we stained bladders 24 hr after
infection for IL-10 and the MC-specific protein MMCP6 (Fig-
ure 6E). Although our real-time PCR data suggest that MCs
contribute to maintaining the basal levels of IL-10 expression
(Figure 6B), staining for this cytokine in the tissues of saline
control mice did not reveal striking levels of IL-10 (Figure 6F).
Background staining for IL-10 also could not be detected in
Il10/ mice (data not shown), yet infected IL-10-sufficient
animals showed strong colocalization of IL-10 with MMCP6 (Fig-
ure 6F). In addition to MCs, other cell populations such as Treg
cells and macrophages have the ability to produce and
contribute to IL-10 levels in the bladder (Couper et al., 2008).
To confirm thatMCs are themajor source of IL-10 upon infection,
we stained single-cell suspensions of infected bladders intracel-
lularly for IL-10 and analyzed the IL-10-producing cell popula-
tions by flow cytometry. Although the Treg cell and macrophage
compartments contribute to the pool of IL-10+ cells in the
bladder (Figure 6G), the majority of IL-10+ cells were CD117+
MCs (Figure 6F). We also detected increased secreted IL-10
protein in the urine of infected WT, but not Wsh, mice (Figures
S5A–S5C), supporting our theory that MCs are the predominate
contributors of IL-10 to the bladder microenvironment.
To verify that enhanced cellular trafficking during infection is
MC dependent, we reconstituted Wsh mice with bone-
marrow-derived MCs (BMMCs) (Figures S5D and S5E), resulting
in rescue of LN hypertrophy (Figure S5F) and influx of neutrophils
(Figure S5G). We also saw an increase in Il10 expression in
bladders of infected but not IL10/ BMMC-reconstituted Wsh
mice (Figure 6H) and, comparable to WT mice, there were
greater numbers of activated DCs draining to the RLN as
compared to the ILN (Figure 6I). More importantly, when Wsh354 Immunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc.mice were reconstituted with Il10/ BMMCs, the proinflamma-
tory responses were restored, with abundant activated DCs in
DLNs and equivalent cell numbers in the ILN and RLN (Figure 6I).
This observation was similar to that seen, phenotypically, in
Il10/ mice (Figure 5B). Because the proposed role of MC-
derived IL-10 in sterile inflammatory responses (Grimbaldeston
et al., 2007) has recently been contested and was alternatively
explained to be potentially due to the neutrophilia phenotype
of the Wsh model (Dudeck et al., 2011), we verified that neutro-
phil depletion did not affect the augmented production of IL-10
by MCs or activation of DCs (Supplemental Information and
Figures S5H–S5K). Additionally, to definitively show the contrib-
uting role of MC-derived IL-10 in the tolerogenic bladder micro-
environment, we used an established Cre-Lox recombination
model with the Cre gene under the regulation of the MC
protease-5 (Mcpt5) promoter and the Il10 gene flanked with
loxP sites (Dudeck et al., 2011). In these mice, only MCs are defi-
cient in IL-10 (Mcpt-Cre Il10fl/fl). In Mcpt-Cre Il10fl/fl mice, we
observed similar phenotype to Il10/mice: significantly greater
numbers of activated mature DCs draining to the RLNs during
infection (p < 0.01) (Figure 6J). Without the effects of MC IL-10,
UPEC-specific antibodies were detectable in the sera of
cystitis-infected Mcpt-Cre Il10fl/fl mice (Figure 6K). It should
also be noted that the levels of Il10 expression in the bladder
24 hr p.i. were comparable between Mcpt-Cre Il10fl/fl mice,
Wsh mice, and Wsh mice reconstituted with Il10/ BMMCs
(Figure 6H). These data point to MC-derived IL-10 as a major
factor constricting DC activation upon infection, specifically
within the ILN but not RLN. These studies show that the adaptive
immune response initiated from the DLN of the bladder is lower
than that of the kidneys and, furthermore, suggest that themuted
initiation of adaptive immunity observed in cystitis, but not pyelo-
nephritis, is due to the immunosuppressive effects of predomi-
nantly MC-derived IL-10 in the bladder.
MC-Derived IL-10 Promotes Bladder Bacterial
Persistence
In spite of the role we observe for IL-10 in permitting long-term
bacterial persistence (Figure 4H) and the critical role MCs play
in contributing to IL-10 production in the bladder during infection
(Figures 6B and 6C), these cells are not dispensable during the
acute phase of infection. Indeed, the first and primary response
of MCs is proinflammatory and, perhaps, it is as a result of this
lack of proinflammatory response that Wsh mice have a greater
bacterial burden in the bladder compared to WT mice 6 weeks
p.i. (Figure S6A), despite the fact that initial intracellular bacterial
burden is similar only 4 hr p.i. (Figure S6B). Wsh mice also ex-
hibited lower antibody titers upon pyelonephritis infection (Fig-
ure S6C) and these defects in adaptive responses probably
underlie the long-term elevated bacterial burden in Wsh mice.
To investigate the contributions of the IL-10-mediated immu-
nosuppression by MCs to UPEC clearance in the bladder, while
retaining the immunesurveillance capacity of MCs within the
bladder and their contributions to promoting adaptive immune
responses, we reconstituted mice with Il10/ BMMCs. This
experiment revealed that the elevated level of MC-derived
IL-10 in the bladders of WT mice during infection promotes the
persistence of bacteria, because these Il10/ BMMC-reconsti-
tuted mice had a greatly reduced intracellular bacterial reservoir,
Figure 6. MCs in the Bladder Promote Il10 Expression
(A) A whole-mount picture of the luminal side of a murine bladder, showing the abundance of MCs (red, avidin-TRITC stained) under the epithelium.
(B) Wsh mice, even at basal levels, have lower expression of Il10 in the bladder as compared to WT bladders, determined by real-time PCR.
(C) With infection, at 6 hr after bacterial instillation, Il10 expression increases in bladders of WT but not Wsh mice.
(D) Il10 is expressed at higher basal levels in the kidneys of Wsh compared to WT mice, as determined by real-time PCR.
(E) However, upon infection, the high Il10 levels of expression in Wsh kidneys drop dramatically to be not significantly different from those of WT kidneys at 6 hr.
(F) Image shows a bladder section stained for MCs (MMCP6, green) and for IL-10 (red) 24 hr after UPEC infection.
(G) Intracellular staining for IL-10 reveals IL-10+ cells in the bladder 24 hr p.i. Though Treg cells (Foxp3+CD4+) and macrophages (MHC-II+CD11b+) contribute to
the IL-10 in the bladder, the majority of cells that are IL-10+ are MCs (c-kit+).
(H) Rescue of increased Il10 expression is seen in infected bladders of Wsh mice reconstituted with WT BMMCs but not Il10/ BMMCs at 24 hr p.i.
(I) Wsh mice reconstituted with WT BMMCs have significantly greater activated DCs draining to the RLNs compared to ILNs 24 hr p.i. Reconstitution with BMMC
from Il10/mice results in comparable numbers of activated DCs in both LNs. *p < 0.05, **p% 0.01, ***p% 0.001; data are representative ofR3 independent
experiments with nR 3. Error bars represent ±SEM.
(J) Mcpt5-Cre Il10fl/fl mice showed the same phenotype as Il10/mice and Il10/ BMMC-reconstituted Wsh mice: significantly greater numbers of mature DCs
present in both ILN and RLN as compared to WT ILNs 24 hr p.i.
(K) Serum UPEC-specific IgG was detected in Mcpt5-Cre Il10fl/fl mice 7 days p.i. Error bars represent the 95% confidence level with n = 5.
See also Figure S5.
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Figure 7. MC-Derived Il10 Promotes Bacterial Persistence in
Bladder
(A) Wsh mice reconstituted with Il10/ BMMCs had significantly lower
persistent bacteria in bladders compared to both WT mice and Wsh mice
reconstituted with WT BMMCs. Bladders were harvested 2 weeks p.i. (1 3
108 UPEC) for quantification of bacterial persistence by CFU.
(B) This phenotype was also observed in Il10/ and Mcpt5-Cre Il10fl/fl mice.
The bladders of WT mice retained significantly greater numbers of intracellular
bacteria 6 weeks p.i.
(C) Increased numbers of MCs are present in the bladder at 24 hr, as deter-
mined by quantification from tissue sections.
(D) This increase of MCs persisted in the bladder 6 weeks p.i.
*p < 0.05, **p% 0.01; n = 3. Error bars represent ±SEM. See also Figure S6.
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reconstituted mice (Figure 7A). It is of note that the same pheno-
type was observed in Mcpt5-Cre Il10fl/fl mice and Il10/ mice,
whereas WT bladders retained greater numbers of intracellular
bacteria (Figure 7B). Interestingly, we also observed that the
numbers of MCs within bladders were augmented by 24 hr in in-
fected mice by 30%, compared to controls (Figure 7C). This
augmented MC population persists in the bladder, as shown
by the fact that the MC numbers at 6 weeks p.i. were still signif-
icantly increased (p < 0.05) (Figure 7D). Therefore, it appears that
MCs in the bladder serve a unique function of maintaining IL-10
levels in the resting state and promoting IL-10 production after
the initial proinflammatory response by MCs to cystitis, thus re-
sulting in a localized immunosuppressive environment in the
bladder. This inhibitory response may be further augmented
during infection through the recruitment of additional MCs into
the bladder, which persists alongside the hidden intracellular
bacteria population.356 Immunity 38, 349–359, February 21, 2013 ª2013 Elsevier Inc.DISCUSSION
The bladder’s primary task is to store excreted products in the
form of urine. However, like many other mucosal surfaces, its
virtually inevitable exposure to external microbial pathogens
(which make their way up the urethra to colonize urine) warrants
efficient tissue-specialized defenses to maintain sterility. The
initial barriers to pathogens within the bladder are physical,
such as the highly impermeable urothelium and the flushing
actions of urine flow. Should pathogens, such as UPEC, breach
this layer and initiate infection, the bladder is also equipped to
respond with a vigorous proinflammatory primary immune
response including the production of cytokines and a substantial
neutrophil influx. However, during bladder infection, we and
others (Malaviya et al., 1999; Mulvey et al., 2001; Mysorekar
and Hultgren, 2006) observe persistence of infection and notable
defects in the ability of the host to mount an adaptive immune
response (Percival et al., 1964; Ratner et al., 1981; Rene and
Silverblatt, 1982; Sanford et al., 1978; Winberg et al., 1963).
These unexpected limitations are characteristic of a broadly tol-
erogenic transcriptional program (including the upregulation of
Tgfb and Socs3) in the bladder upon infection and dependent
on the specific upregulation within the bladder of the anti-inflam-
matory cytokine IL-10. This upregulation is not seen in infected
kidneys, leading us to conclude that the tempering of adaptive
immune responses and associated increase of Il10 expression
is a bladder-specific phenomenon to promote a tolerogenic
microenvironment. Using mice deficient in IL-10, we examined
various facets of the adaptive immune response to cystitis alone
or pyelonephritis and observed that IL-10 competency signifi-
cantly decreases DC activation and numbers of CD4+ T cells
and germinal center B cells in DLNs. Because Il10/ animals
are also capable of producing comparable humoral responses
after cystitis to mice with pyelonephritis, we expect that the
uniquely elevated production of IL-10 by infected bladders but
not kidneys explains the divergent outcomes that we and others
(Percival et al., 1964; Ratner et al., 1981; Rene and Silverblatt,
1982; Sanford et al., 1978) observe with regards to adaptive
immunity during cystitis versus pyelonephritis.
Subsequent investigations revealed that MCs, which produce
IL-10 in infected bladders, are a major driving force behind this
immunosuppressive response in the bladder, because infected
MC-deficient bladders have reduced levels of Il10 compared to
controls. Grimbaldeston et al. (2007) have reported that that
MC-derived IL-10 suppresses inflammatory responses in a cuta-
neous sterile inflammation model; however, recently, Dudeck
et al. (2011), using a novel MC-deficient model, found that
IL-10 fromMCs is not relevant for suppression of contact hyper-
sensitivity (CHS) and attributed the increased inflammation in
Wsh mice to the kit mutation. It should be noted that the cuta-
neous sterile inflammation protocols employed in these two
models differ significantly and it has been demonstrated that
the sensitization dose can be critical for MC-dependent
outcomes during CHS (Norman et al., 2008). In view of the
discordance between these reports, we sought to verify findings
obtained here by using the Wsh mouse/reconstitution model by
employing a c-kit-independent model where only MCs were Il10
deficient. Using consistent methods, these two models
produced consistent results, supporting a role of MC-derived
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findings also indicate that with regard to bladder infections, the
role of MCs remained the same regardless of whether c-kit-inde-
pendent or -dependent MC-targeting mouse models are used.
We have previously shown that MCs play a vital role in orches-
trating the immune response during bacterial infection (Malaviya
et al., 1996; McLachlan et al., 2003; Shelburne et al., 2009). Here,
the observation that MCs also express substantial amounts of
IL-10 during bladder infection suggests that MCs in the bladder
play a dual role: first, promoting inflammation to infection and,
later, limiting it. In contrast to the bladder, Il10 levels are
increased at basal levels in the kidneys of mice lacking MCs.
Therefore, just as the bladder and the kidney have different
responses to infection, the MCs in these two tissues appear to
have differing regulatory roles in tuning the inflammatory profile
of the tissues in the resting state. This could be due to tissue-
specific heterogeneity in MC function (Bienenstock et al., 1985;
Kitamura, 1989; Rao and Brown, 2008), a topic that requires
further investigation.
One can speculate that MC-driven production of IL-10 in the
bladder may relate to its unique storage function. Urine
contains many intact host proteins filtered by the kidneys
(Adachi et al., 2006; Barratt and Topham, 2007) to which immu-
nological tolerance must be maintained. It is interesting to note
that the delayed MC-mediated Il10 expression coincides with
the time frame when the bladder sheds its superficial epithelium
in the early hours of infection in an attempt to reduce bacterial
burden (Mulvey et al., 2000). The induction of proinflammatory
cytokines in the bladder is much higher than those seen in
the kidneys, and the contraction of the inflammatory response
within the bladder may be for the purposes of tempering harm-
ful immune responses to the many antigens in urine when the
protective epithelial coating is lost or to facilitate regeneration
of the superficial epithelium and restore the bladder’s critical
barrier function. It is notable that IL-10 has been associated
with wound repair in multiple contexts (Carrington et al.,
2006; Liechty et al., 2000; Sawa et al., 1997). Abrogation of
adaptive immune responses in the bladder might not be detri-
mental to a host that is capable of clearing infection the vast
majority of the time with its vigorous innate immune response.
In this case, the risk of breaking tolerance to an associated
self- or modified self- antigen could be more detrimental than
the risk of not fully eliminating a largely contained infection.
In this way, the bladder, like the gut, may have highly organ-
specialized strategies for balancing the need for tolerance
to its contents and the imperative of resisting microbial
exploitation.
The host’s muted adaptive immune response to cystitis could
also explain why the bladder is unable to fully eradicate the
persistent population of bacteria that can be detected for weeks
after infection. Remarkably, bacterial persistence occurs in
parallel to elevated MC numbers in the bladder, implying
a role for these recruited MCs in promoting bacterial persis-
tence. Residual intracellular E. coli could contribute to the clin-
ical phenomenon of frequent cystitis recurrences, because
1/3 of recurrent cystitis is caused by the original infecting
strain (Ika¨heimo et al., 1996). Many studies have revealed that
bacteria-associated determinants of pathogenesis can influ-
ence infection (Connell et al., 1996; Johnson, 1991; Nielubowiczand Mobley, 2010), but this propensity toward recurrence could
also be attributable to the failure of the host to form protective
immunological memory after primary cystitis, which we observe
in our murine model. Although some groups have observed that
bladder infection can generate productive primary adaptive
immune responses (Thumbikat et al., 2006) and others have
emphasized the importance of bacteria-associated factors to
disease progression (Connell et al., 1996; Johnson, 1991; Nielu-
bowicz and Mobley, 2010), our work may explain why bladder-
confined infections are less frequently cleared than those that
progress to pyelonephritis. However, the results from this study
also highlight the potential of cystitis to elicit an effective
secondary immune response once immunological memory
has been established, because animals that have previously
experienced pyelonephritis have significantly increased UPEC-
specific antibody responses during cystitis compared to those
having had cystitis previously. Therefore, while emphasizing
the unique microenvironment of the bladder as tailored to
suppress primary adaptive responses, our findings inform us
that UTI treatment and vaccination strategies are plausible
because, particularly when immunological memory has already
been formed, adaptive immune responses can be elicited by
bladder infection.
EXPERIMENTAL PROCEDURES
Mice and UTI Infections
6- to 8-week-old C57BL/6 female mice obtained from NCI were used for most
animal studies. MC-deficient (Wsh), Il10-deficient (Il10/), and Mcpt-5Cre
Il10fl/fl mice, all on C57BL/6 backgrounds, were bred at the Duke University
Medical Center animal care facility. Wsh mice were reconstituted by i.v. injec-
tion of 13 107 BMMCs and allowed 15 weeks for MCmaturation in tissues. All
animal experiments were approved by the Duke University IACUC and Division
of Laboratory Animal Resources. Mice were catheterized for inoculation of 108
E. coli transurethrally with clinical isolate UPEC strains J96 (Normark et al.,
1983) or CI5 (Abraham and Arock, 1998; Mulvey et al., 2001) under pentobar-
bital anesthesia. To exclusively initiate cystitis, the bladder was inoculatedwith
30 ml at a slow rate (2.5 ml/s). For combined bladder and kidney infection, 50 ml
was given at a fast rate (10 ml/s).
Flow Cytometry from LN, Bladder, and Kidney Suspensions
To quantitate DCs, single-cell suspensions of lymphoid tissues were stained
with the following antibodies: a-MHCII-FITC (eBioscience), a-CD11c-PE-
Cy5.5 (eBioscience), and for detection of activation, a-CD86-PE (eBioscience).
To stain germinal center B cells and T helper cells, we used a-CD19-
PE (eBioscience) and a-GL7-FITC (BD PharMingen) or a-CD4-PE-Cy5.5
(eBioscience). For intracellular staining of Foxp3 (eBioscience) and IL-10
(eBioscience), cells were permeabilized with 0.1% saponin. Cells were fixed
in 4% paraformaldhyde prior to flow cytometry with a FACscaliber (BD Biosci-
ences) and analysis by CellQuest software.
Statistical Analysis
We determined significance by unpaired two-tailed Student’s t test to assess
data with two groups or by one- or two-way analysis of variance and Tukey’s
multiple comparison or Bonferroni posttests, as appropriate, for all other
experiments. All graphs and analyses were done with Prism (Graphpad)
software.
SUPPLEMENTAL INFORMATION
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